Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02730806
Other study ID # WEINNLPCTIL
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 27, 2017
Est. completion date December 20, 2019

Study information

Verified date August 2019
Source Assuta Hospital Systems
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this interventional study is to evaluate the effectiveness of the NLP PTSD protocol in the event of PPPTSD. The study's main hypothesis is that the implementation of the NLP protocol will be effective and result in reduction of the overall PTSD level.


Description:

Post Traumatic Stress Disorder (PTSD) is considered to be a major Public Health disorder in the Western world with 8% prevalence. When including partial/Sub-clinic PTSD, prevalence rises dramatically. Studies examining the common intervention methods indicate certain clinical effectiveness although none presents sweeping efficiency. Therefore, this syndrome is still a significant clinical problem in Public Health.

This study focuses on women population who have experienced trauma in childbirth. Such women experience full post traumatic symptoms (Full PTSD) or Partial/Subclinical PTSD. This syndrome is defined in professional literature as PPPTSD (Post-Partum Post Traumatic Stress Disorder). While childbirth is a healthy part of the cycle of life, birth itself is an event that may involve a risk to the mother and child life. PPPTSD prevalence ranges between 1%-6% and is expressed in at least two of the criteria listed in the DSM. 8.3%-28% of women suffer from partial PPPTSD.

Neuro Linguistic Programming (NLP) is a "one-on-one" intervention method, connecting Neurological processes (N), Linguistic (L) and learned behaviors (P), in order to allow conceptual/perceptual, mental and behavioral changes. Even though NLP is used since the 1970's and field testimonies report its effectiveness, there are only few studies regarding its effectiveness in the field of PTSD.

This study's main objective is to examine the effectiveness of the NLP PTSD protocol.

The study population will include approx 30 women, up to 2 years after birth, with PPPTSD. The women will be treated in 5 individual sessions implementing the NLP PTSD protocol.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date December 20, 2019
Est. primary completion date December 14, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

1. Women

2. Age: 18-40

3. 2 years from the date of birth;

4. PTSD or PTSD symptoms (indicating partial PTSD) diagnosed as a leading problem in the participant's life

5. Hebrew speaking

6. Insured by Maccabi Health Services

Exclusion Criteria:

1. Presence of one of the following:

(A) Mental retardation; (B) Schizophrenia or other mental illnesses;

2. Changes in medication dose during the study or during the three prior months;

3. Suicide attempts or self-harm;

4. Alcohol or drug use;

5. Postpartum depression;

6. Incompetent

7. Stillbirth

Study Design


Intervention

Behavioral:
NLP
NLP techniques, such as VKD, visual/auditory/kinesthetic swishes, modified especially for PTSD, will be implemented one-on-one with each woman in this arm.

Locations

Country Name City State
Israel Mental Health Clinic Rishon Le'Zion

Sponsors (2)

Lead Sponsor Collaborator
Yfat Weinstein-Zohar Maccabi Healthcare Services, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary PTSD (PCL-C) - PTSD checklist - measures the change in the overall level of PTSD A Self-report questionnaire diagnoses the severity of PTSD (PCL-C), conducted before and after the intervention, enables to examine the overall level of PTSD (PTSD volume). Developed by Weathers et al, 1993, based on criteria appearing in DSM- V, it includes 20 questions, with each item testing the presence and the severity of one of the symptoms of PTSD during the passing month. Answers are based on the Leickert scale with 5 degrees ranging from 0 ("never") to 4 ("very much"). Overall measurement ranges from 0 to 80 (PTS - Post Traumatic Symptoms). Cut mark for the estimation of PTSD >= 44. Through study completion, an average of 1 year
Primary PTSD (PCL-C) - PTSD checklist - measures also the change in the levels of PTSD symptoms: intrusion/re-experiencing, avoidance, arousal and negative alterations in cognitions and mood A Self-report questionnaire diagnoses the severity of PTSD (PCL-C), conducted before and after the intervention, enables to examine also the levels of PTSD symptoms: intrusion/re-experiencing avoidance, arousal and negative alterations in cognitions and mood. Developed by Weathers et al, 1993, based on criteria appearing in DSM- V, it includes 20 questions, with each item testing the presence and the severity of one of the symptoms of PTSD during the passing month. Questions are presented in four groups, which express the four main symptom clusters in PTSD: intrusion/re-experiencing (items 1-5) (criteria B), avoidance (items 6-7) (criteria C), negative alterations in cognitions and mood (items 8-14) (criteria D), and hyper-arousal (items 15-20) (criteria E). Through study completion, an average of 1 year
Secondary Functioning Questionnaire - measures the change in overall subjects' Functioning Level This questionnaire, developed by Gelkopf et al 2011, will be conducted before and after the intervention.The questionnaire evaluates 6 functioning aspects in the passing month: occupation, studies, parenting, relationship with the spouse, being part of the community, friendship and intimacy. The answers are based on the Leickert scale with 5 degrees ranging from 0 ("very bad") to 4 ("very good"). The internal consistency is a = 0.86 (range 0-4, SD=0.79, M=3.20). Through study completion, an average of 1 year1
Secondary Post Traumatic Growth Inventory (PTGI) - measures the change in the overall level of PTG This questionnaire, developed by Tedeschi & Calhoun, 1996, will be conducted before and after the intervention. It includes 22 items divided to 5 sub-scales: connection with others, new opportunites, personal strength, spiritual change and life appreciation. The subjects are asked to rate their answer concerning the amount of change they experienced in their life due to the traumatic event. The answers are based on the Leickert scale with 5 degrees ranging from 0 ("not at all") to 4 ("very much"). The internal consistency is a = 0.96. Through study completion, an average of 1 year.
See also
  Status Clinical Trial Phase
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Withdrawn NCT00641173 - Early Intervention for Post Traumatic Stress Disorder (PTSD) N/A
Completed NCT00564317 - KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka Phase 3
Recruiting NCT02512445 - Trauma Informed Guilt Reduction Therapy N/A
Completed NCT00100490 - Immune and Endocrine Function in Post-Traumatic Stress Disorder N/A
Terminated NCT03605342 - Optimal Treatment of Veterans With PTSD and Comorbid OUD Phase 2
Terminated NCT02824445 - To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder N/A
Recruiting NCT03152175 - Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators Phase 2
Completed NCT02080351 - A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident N/A
Completed NCT00974402 - Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings N/A
Recruiting NCT00134446 - Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder Phase 4
Not yet recruiting NCT02384369 - Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder Phase 2
Completed NCT00120250 - Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder Phase 4
Completed NCT00039715 - Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder N/A
Recruiting NCT04368689 - The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD N/A
Completed NCT01060553 - Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD N/A
Completed NCT00227357 - The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration N/A
Completed NCT02927288 - Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy N/A
Completed NCT01278316 - Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study N/A
Completed NCT00778960 - Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder. N/A